| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.JCHROMB.2006.10.069 |
| P698 | PubMed publication ID | 17140865 |
| P2093 | author name string | David W Speicher | |
| Won-A Joo | |||
| Seth A Hoffman | |||
| Lynn A Echan | |||
| P433 | issue | 1-2 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 43-52 | |
| P577 | publication date | 2006-11-30 | |
| P1433 | published in | Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences | Q2422407 |
| P1476 | title | Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma | |
| P478 | volume | 849 |
| Q33545430 | A gel-free approach in vascular smooth muscle cell proteome: perspectives for a better insight into activation |
| Q37257661 | Analysis of human plasma proteins: a focus on sample collection and separation using free-flow electrophoresis |
| Q33338835 | Biomarker discovery in psychiatric disorders |
| Q34111926 | Comparative proteomics analysis of serum proteins in ulcerative colitis patients |
| Q46760323 | Comprehensive and quantitative proteome profiling of the mouse liver and plasma |
| Q37672093 | Current technological challenges in biomarker discovery and validation |
| Q37802868 | Development of multidimensional liquid chromatography and application in proteomic analysis |
| Q31043570 | Early diagnostic protein biomarkers for breast cancer: how far have we come? |
| Q41553854 | Efficient Quantitative Comparisons of Plasma Proteomes Using Label-Free Analysis with MaxQuant |
| Q36188829 | Enhanced Detection of Low-Abundance Human Plasma Proteins by Integrating Polyethylene Glycol Fractionation and Immunoaffinity Depletion |
| Q34116114 | Functional protease profiling for diagnosis of malignant disease |
| Q48536502 | Global proteomic profiling reveals altered proteomic signature in schizophrenia serum |
| Q33900798 | High abundance proteins depletion vs low abundance proteins enrichment: comparison of methods to reduce the plasma proteome complexity. |
| Q36721347 | Identification of multiple novel protein biomarkers shed by human serous ovarian tumors into the blood of immunocompromised mice and verified in patient sera |
| Q41361822 | In-Depth, Reproducible Analysis of Human Plasma Using IgY 14 and SuperMix Immunodepletion |
| Q33457379 | Liquid chromatography-mass spectrometry: a tool for proteome analysis and biomarker discovery and validation |
| Q37484011 | Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective |
| Q37434154 | More than apples and oranges--detecting cancer with a fruit fly's antenna |
| Q36841889 | Oncoproteomics: current trends and future perspectives. |
| Q28540277 | Optimization of plasma sample pretreatment for quantitative analysis using iTRAQ labeling and LC-MALDI-TOF/TOF |
| Q35169971 | Plasma biomarker discovery using 3D protein profiling coupled with label-free quantitation |
| Q34018095 | Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer |
| Q38038568 | Potential biomarkers for early detection of acute graft-versus-host disease |
| Q40194995 | Potential serum biomarkers associated with mild and severe leptospirosis infection: A cohort study in the Malaysian population. |
| Q39967758 | Proteomics methods and applications for the practicing clinician |
| Q38268959 | Proteomics of the periconception milieu |
| Q33959585 | Quantification of proteins using data-independent analysis (MSE) in simple andcomplex samples: a systematic evaluation |
| Q35194600 | Rapid verification of candidate serological biomarkers using gel-based, label-free multiple reaction monitoring |
| Q37090840 | Recent development of multi-dimensional chromatography strategies in proteome research |
| Q35169678 | Search for breast cancer biomarkers in fractionated serum samples by protein profiling with SELDI-TOF MS. |
| Q37587875 | Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. |
Search more.